Chlamydia, the Silent STD That Can Cause Infertility

Chlamydia infection is the most common sexually transmitted disease, responsible for a record 1.1 million cases reported to the Centers for Disease Control and Prevention in 2007, and experts there estimate that twice that many cases go undetected. Left untreated, chlamydia can cause infertility or potentially fatal ectopic pregnancies. But many women aren’t even aware that they were exposed to it—possibly years ago—until they try to have a baby and can’t.

Chlamydia can be detected with a simple urine test. It can be treated with a single dose of antibiotics, and the CDC has been urging all sexually active women under 26 years old to be tested for it annually, as well as older women who have had a change of sexual partner. Yet fewer than 40 % of women in those categories are being screened.

Even when women are treated for chlamydia, about 25% become reinfected within six months—probably due to a partner who wasn’t treated. So the CDC recommends that doctors give women a second course of antibiotics for their partners, even without being seen by a doctor themselves. It can be treated either with a weekly dose of doxycycline or a single dose of azithromycin, which goes by the brand name Zithromax, made by Pfizer Inc., in many countries.

Most official efforts are focused on detecting active chlamydia infections in young women. But what if you think you were exposed years ago? The main risk is to fertility. The CDC recommends that all pregnant women be tested for chlamydia at the first prenatal visit, although if you are planning to become pregnant, it’s a good idea to be tested for all STDs well in advance. Older women who are experiencing pelvic pain, intermittent bleeding, unusual vaginal discharge or signs of early menopause should ask their doctor if chlamydia could be involved.

For the complete article, please refer to http://online.wsj.com/article/SB10001424052970203937504574252362862563486.html

Partner Notification Essential in Chlamydia, New Guidelines Say

Partner notification and treatment needs to be at the centre of chlamydia treatment programmes, new European guidelines urge.

European Centre for Disease Control (ECDC) guidance issued this week says that notification and management of partners of those with chlamydia should form an essential part of case management.

Consideration should also be given to providing partners with home testing kits or antibiotics for treatment, the guidelines say.

The ECDC reviewed chlamydia control activities in 29 European countries and found wide variation in the provision of services.

The centre believes that surveillance of chlamydia prevalence and treatment across Europe needs to improve.

For the complete article, please refer to http://www.healthcarerepublic.com//news/index.cfm?fuseaction=HCR.RSS.News.Article&nNewsID=916861#AddComment

Causes Behind Development of Hepatitis B&C

Hepatitis is one of the prominent health problems. Many illnesses and conditions can cause inflammation of the liver. Hepatitis is most often viral, due to infection with one of the hepatitis viruses (A, B, C, D, and E) or another virus (such as those that cause infectious mononucleosis, cytomegalovirus disease, or yellow fever).

Hepatitis B virus

It is a rigorous disease caused by a virus that harms the liver. It is commonly known as hepatitis B virus (HBV). It can cause a wide number of symptoms ranging from general malaise to lifelong infection, cirrhosis of the liver, liver cancer, liver failure, and death.

HBV spreads by contaminated body fluids, such as blood, saliva, semen, vaginal fluids, tears, and urine, an infected blood transfusion, shared infected needles or syringes for injecting drugs, sexual activity with an HBV-infected individual, and transmission from HBV-infected mothers to their newborn infants.

Hepatitis C virus

It is one of the common liver disease caused by a virus known as HCV(hepatitis C virus). Infection with the hepatitis C virus can cause chronic liver disease and is the leading reason for liver transplant . HCV is spread by direct contact with an infected person’s blood, getting a tattoo or body piercing with non sterilized tools, sharing drug needles, sexual contact with infected person.

For the complete article, please see http://www.webarticles.co.za/articlebase/?p=6967

Hepatitis A and Hepatitis B Vaccine

Hepatitis A and hepatitis B vaccine will not protect you against infection with hepatitis C or E, or other viruses that affect the liver. It will also not protect you from hepatitis if you are already infected with the virus, even if you do not yet show symptoms.

Vaccination with hepatitis A and hepatitis B is recommended for all adults who are at risk of getting hepatitis A or B. Risk factors include: having more than one sex partner in 6 months; being a homosexual male; having sexual contact with infected people; having cirrhosis or chronic hepatitis C; using intravenous (IV) drugs; being on dialysis or receiving blood transfusions; working in healthcare or public safety and being exposed to infected blood or body fluids; being in the military or traveling to high-risk areas; and living with a person who has either hepatitis A or B infection.

Hepatitis A and B are serious diseases caused by virus. Hepatitis A is spread through contact with the stool (bowel movements) of a person infected with the hepatitis A virus. This usually occurs by eating food or drinking water that has become contaminated as a result of handling by an infected person.

Hepatitis B is spread through blood or bodily fluids, sexual contact or sharing IV drug needles with an infected person, or during childbirth when a baby is born to a mother who is infected. Hepatitis causes inflammation of the liver, vomiting, and jaundice (yellowing of the skin or eyes). Hepatitis can lead to liver cancer, cirrhosis, or death.

Your doctor or pharmacist may have information about this vaccine written for health professionals that you may read. You may also find additional information from your local health department or the Centers for Disease Control and Prevention.

For the complete article, please refer to http://www.drugs-journal.co.cc/drug-1514-hepatitis-a-and-hepatitis-b-vaccine.html

Risk Of Liver Cancer In Women With Hepatitis B Virus Infection Varies With Number Of Pregnancies

Risk for hepatocellular carcinoma, a primary malignancy of the liver, was statistically significantly higher among women with hepatitis B virus (HBV) infection than among women without the virus, according to a study published online June 17 in the JNCI.

Because hepatocellular carcinoma mostly occurs in men, few women have been included in long-term studies of the association between HBV infection and this carcinoma.

The more children a woman had, the lower her risk appeared to be. This inverse relationship between parity and the risk of hepatocellular carcinoma was statistically significant. “Underlying biological mechanisms responsible for this…merit further investigation,” the authors write.

For the complete article, please refer to http://www.medicalnewstoday.com/articles/154531.php

One In Four Teenage Girls In U.S. Has Sexually Transmitted Disease, CDC Study Shows

A new CDC study estimates that one in four (26 percent) young women between the ages of 14 and 19 in the United States — or 3.2 million teenage girls — is infected with at least one of the most common sexually transmitted diseases (human papillomavirus (HPV), chlamydia, herpes simplex virus, and trichomoniasis).

The two most common STDs overall were human papillomavirus, or HPV (18 percent), and chlamydia (4 percent). Data were based on an analysis of the 2003-2004 National Health and Nutrition Examination Survey.

For the full article, please refer to http://www.sciencedaily.com/releases/2008/03/080312084645.htm

Antiviral Medications Have Proven Clinical Effectiveness Against Genital Herpes

Antiviral medications have proven clinical effectiveness against genital herpes. Here is a snapshot of the three most commonly prescribed medications; Acyclovir (Zovirax), Famciclovir (Famvir) and Valacyclovir (Valtrex).

Acyclovir helps to prevent the herpes virus from spreading to other cells. It is used in the treatment of genital herpes, but also chickenpox and shingles. Acyclovir is available as tablets, capsules, an ointment, a suspension or as an injection. In ointment form it may be applied directly to the affected area. This is known to reduce pain, help limit the spread of infection and speed up the healing process. During the first outbreak of genital herpes a typical prescription is along the lines of tablets or capsules, 400 mg, three times a day for up to 10 days. This may vary slightly. Acyclovir may also be used in cases of recurrent outbreaks and, where more than six outbreaks occur in a year, it can be taken daily.

Famciclovir also helps to prevent the herpes virus from spreading to other cells. Like acyclovir it does not cure or prevent the spread of herpes. Famciclovir is available as a tablet for the treatment of cold sores (herpes simplex 1) and genital herpes (herpes simplex 2). Its action is broadly similar to Acyclovir in that it helps to relieve itching, burning and pain and speeds up the healing time. Because it has a longer therapeutic effect than acyclovir it can be taken fewer times a day.

Valacyclovir is classed as a prodrug. When taken, valacyclovir is converted to acyclovir in the body. Valacyclovir is available as a cream or in oral or intravenous forms. It has a longer therapeutic duration than acyclovir and can therefore be taken fewer times a day.

For the full article, please refer to http://www.healthcentral.com/genital-herpes/c/52977/70190/famciclovir

Obama urges HIV testing

On the fourteenth National HIV Testing Day President Obama issued a statement supporting annual testing and safe-sex practices.

Obama informed everyone that one in five Americans living with HIV do not know they are infected, and that those people are the ones who transmit HIV the most. However, Obama also noted that once people become aware of their status they take the steps to reduce transmitting HIV to their partners.

While Obama admitted that direct impacts of HIV are not widespread, seeing as how higher rates exist within gay/bisexual men, African Americans, and Latinos – he acknowledged that if a citizen is infected with HIV every nine-and-a-half minutes it affects all Americans.

Using these statistics Obama pledged to implement a comprehensive National HIV/AIDS Strategy (NHAS) to provide better care for those already living with HIV and prevent future transmission in others. However, the government cannot be held responsible for all these practices. Obama urged all Americans to practice safe-sex, regularly get tested, and help eliminate the stigma attached to living with HIV. If the government and the people work together we can decrease the rates of HIV and increase our care towards one another.

Black Gay Men May Be At Increased HIV Risk

In a study looking at social and sexual mixing between ethnic groups in men who have sex with men, researchers show that social barriers faced by black gay men may have a serious impact on their health and well-being.

In the US, there is a disproportionate burden of HIV infection in Black Americans, who accounted for nearly half of all HIV/AIDS cases diagnosed in 2006 – four times the nationaal average.

A total of 1,142 gay men took part in computer-assisted interviews. They were asked about their own ethnicity, the race of their sexual partners in the last six months, their perception of how easy it is to meet sexual partners of different ethnicities, where they meet sexual partners, their view of HIV infection risk and the predominant race of their network of friends.

Black gay men are the least preferred of sexual partners by other races. Black men are perceived to be riskier to have sex with, which can lead to men of other races avoiding Black men as sexual partners. They are also perceived as less welcome in the common social venues of gay men in San Francisco. As a result, Black men are three times more likely to have sexual partners that are also Black, than would be expected by chance alone.

The authors conclude: “The racial disparity in HIV observed for more than a decade will not disappear until the challenges posed by a legacy of racism towards Blacks in the US are addressed.”

For the complete article, please refer to http://www.sciencedaily.com/releases/2009/06/090629114536.htm

Game For HIV Positive Youth Developed

Researchers have developed a game for HIV-positive youth, +CLICK, designed to reduce secondary transmission of the virus.

+CLICK was developed by Christine Markham, Ph.D., and Ross Shegog, Ph.D., assistant professors of behavioral sciences. The game’s usability and credibility were assessed by HIV-positive (HIV+) youth at a Texas Children’s Hospital clinic. Results from the study were published in the May issue of AIDS Care

“We wanted to create +CLICK so that we could help educate youth on the importance of making proper, healthy decisions to protect their relationships and themselves as well as help to reduce transmission of the HIV virus,” said Markham, lead investigator of the study.

The game was developed as an adjunct to the youths’ traditional clinic-based self-management education.

Replicating a shopping mall, study participants travel through lessons on abstinence, condoms and contraception, and also watch video clips from experts and peers who are also HIV+. +CLICK is designed to target four behaviors: choosing not to have sex; disclosing HIV status to a potential partner; using condoms correctly and consistently; and using an effective method of birth control along with condoms.

Participants were able to play several of the game’s lessons in approximately 15 minutes during their regularly scheduled clinic visits. “Participants were very receptive and enthusiastic about playing the game,” said Leonard. “They also liked that they were able to ask the clinicians questions about what they learned on the lessons.”

For the complete article, please refer to http://www.sciencedaily.com/releases/2009/06/090623133525.htm

Categories